Catalyst Pharmaceuticals Inc CN2-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:02 AM CEST
6.39quote price arrow down-0.26 (-3.85%)
52 week range
4.12 - 7.81
Loading...
  • Open6.39
  • Day High6.39
  • Day Low6.39
  • Prev Close6.61
  • 52 Week High7.81
  • 52 Week High Date04/14/22
  • 52 Week Low4.12
  • 52 Week Low Date09/22/21

Key Stats

  • Market Cap726.87M
  • Shares Out102.96M
  • 10 Day Average Volume850
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.82

KEY STATS

  • Open6.39
  • Day High6.39
  • Day Low6.39
  • Prev Close6.61
  • 52 Week High7.81
  • 52 Week High Date04/14/22
  • 52 Week Low4.12
  • 52 Week Low Date09/22/21
  • Market Cap726.87M
  • Shares Out102.96M
  • 10 Day Average Volume850
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.82

RATIOS/PROFITABILITY

  • EPS (TTM)0.38
  • P/E (TTM)16.82
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalyst Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With the patient focus, the Company is engaged in developing a robust pipeline of cutting-edge, medicines for rare diseases. The Company's New Drug Application for FIRDAPSE (amifampridine) tablets 10 milligrams (mg) for the treatment of adults with Lambert-Eaton...
Patrick McEnany
Chairman of the Board, President, Chief Executive Officer
Steven Miller Ph.D.
Chief Operating Officer, Chief Scientific Officer
Alicia Grande CPA
Chief Financial Officer, Vice President, Treasurer
Mary Coleman
Vice President, Head of Investor Relations
Address
355 ALHAMBRA CIRCLE, SUITE 801
Coral Gables, FL
33134
United States